CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹1.01 Cr | - | - | - |
What is the latest Contingent Liabilities ratio of CORONA REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1.01 Cr |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
How is Contingent Liabilities of CORONA REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.01 Cr | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | - | |
Compare Contingent Liabilities of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,748.3 Cr | -2.9% | -0.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -2.9% |
-0.3% |
|
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses